NovoCure Limited (NVCR)
NASDAQ: NVCR · IEX Real-Time Price · USD
19.02
+0.37 (1.98%)
Jul 26, 2024, 4:00 PM EDT - Market closed
NovoCure Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 164.8 | 240.82 | 115.33 | 208.8 | 234.67 | 177.32 | Upgrade
|
| Short-Term Investments | 786.39 | 669.8 | 854.1 | 728.9 | 607.9 | 148.77 | Upgrade
|
| Cash & Short-Term Investments | 951.19 | 910.62 | 969.43 | 937.7 | 842.58 | 326.09 | Upgrade
|
| Cash Growth | 1.10% | -6.07% | 3.38% | 11.29% | 158.39% | 32.62% | Upgrade
|
| Receivables | 97.56 | 66.48 | 98.65 | 101.99 | 110.06 | 80.24 | Upgrade
|
| Inventory | 40.44 | 38.15 | 29.38 | 24.43 | 27.42 | 23.7 | Upgrade
|
| Prepaid Expenses | - | 6.85 | 6.42 | 4.76 | 4.12 | 2.72 | Upgrade
|
| Restricted Cash | 3.65 | 1.74 | 0.51 | 0.81 | 11.5 | 2.1 | Upgrade
|
| Other Current Assets | - | 10.56 | 7.15 | 3.84 | 3.77 | 5.1 | Upgrade
|
| Total Current Assets | 1,093 | 1,034 | 1,112 | 1,074 | 999.44 | 439.95 | Upgrade
|
| Property, Plant & Equipment | 107.27 | 97.7 | 68.96 | 53.88 | 41.63 | 34.6 | Upgrade
|
| Other Long-Term Assets | 12.06 | 14.02 | 11.16 | 12.09 | 10.91 | 4.9 | Upgrade
|
| Total Assets | 1,212 | 1,146 | 1,192 | 1,139 | 1,052 | 479.45 | Upgrade
|
| Accounts Payable | 90.17 | 94.39 | 85.2 | 72.6 | 53.65 | 36.93 | Upgrade
|
| Accrued Expenses | - | 60.18 | 49.44 | 45.39 | 35.66 | 32.92 | Upgrade
|
| Current Portion of Leases | - | 8.22 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | - | 16.22 | 18.03 | 17.76 | 17.77 | 11.77 | Upgrade
|
| Other Current Liabilities | 79.01 | 0.1 | 6.11 | 6.85 | 6.54 | 4.7 | Upgrade
|
| Total Current Liabilities | 169.18 | 179.12 | 158.78 | 142.6 | 113.61 | 86.31 | Upgrade
|
| Long-Term Debt | 653.47 | 568.82 | 565.58 | 562.23 | 429.95 | 149.49 | Upgrade
|
| Long-Term Leases | 21.73 | 27.42 | 18.76 | 13 | 14.29 | 14.14 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 2.88 | 6.48 | 12.14 | 7.81 | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.02 | 0.08 | 0.15 | 0.3 | 0.16 | Upgrade
|
| Total Liabilities | 850.42 | 783.63 | 750.48 | 729 | 575.46 | 261.66 | Upgrade
|
| Additional Paid-In Capital | 1,423 | 1,353 | 1,222 | 1,100 | 1,111 | 871.44 | Upgrade
|
| Retained Earnings | -1,057.64 | -985.5 | -778.46 | -685.93 | -631.08 | -650.89 | Upgrade
|
| Comprensive Income & Other | -3.52 | -5.47 | -2.43 | -3.17 | -3.83 | -2.77 | Upgrade
|
| Total Common Equity | 361.75 | - | - | - | - | - | Upgrade
|
| Shareholders' Equity | 361.75 | 362.5 | 441.17 | 410.49 | 476.53 | 217.79 | Upgrade
|
| Total Liabilities & Equity | 1,212 | 1,146 | 1,192 | 1,139 | 1,052 | 479.45 | Upgrade
|
| Total Debt | 675.2 | 604.47 | 584.34 | 575.23 | 444.24 | 163.63 | Upgrade
|
| Net Cash (Debt) | 275.99 | 306.15 | 385.08 | 362.48 | 398.34 | 162.46 | Upgrade
|
| Net Cash Growth | -21.89% | -20.50% | 6.24% | -9.00% | 145.19% | 68.32% | Upgrade
|
| Net Cash Per Share | 2.58 | 2.88 | 3.68 | 3.50 | 3.66 | 1.67 | Upgrade
|
| Filing Date Shares Outstanding | 108.22 | 107.09 | 105.46 | 104.42 | 102.41 | 99.64 | Upgrade
|
| Total Common Shares Outstanding | 108.01 | 107.08 | 105.05 | 103.97 | 102.33 | 99.53 | Upgrade
|
| Working Capital | 923.66 | 855.29 | 952.75 | 930.92 | 885.83 | 353.64 | Upgrade
|
| Book Value Per Share | 3.35 | 3.39 | 4.20 | 3.95 | 4.66 | 2.19 | Upgrade
|
| Tangible Book Value | 361.75 | 362.5 | 441.17 | 410.49 | 476.53 | 217.79 | Upgrade
|
| Tangible Book Value Per Share | 3.35 | 3.39 | 4.20 | 3.95 | 4.66 | 2.19 | Upgrade
|
| Land | - | 24.7 | 15.99 | 11.16 | - | - | Upgrade
|
| Machinery | - | 43.05 | 30.94 | 26.56 | 23.32 | 19.17 | Upgrade
|
| Leasehold Improvements | - | 11.7 | 9.35 | 7.08 | 6.5 | 4.82 | Upgrade
|
Source: S&P Capital IQ. Standard template.